C‐reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion

Background  Impaired perfusion of the heart induces a local inflammatory response, which involves deposition of C‐reactive protein and complement activation products C3d and C5b‐9. We investigated whether reperfusion or reinfarction enhances these phenomena in humans.

[1]  Prapat Suriyaphol,et al.  Possible Protective Role for C-Reactive Protein in Atherogenesis: Complement Activation by Modified Lipoproteins Halts Before Detrimental Terminal Sequence , 2004, Circulation.

[2]  C. Visser,et al.  C-reactive protein activates complement in infarcted human myocardium. , 2003, The American journal of pathology.

[3]  H. Wellens,et al.  Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarction. , 2002, European heart journal.

[4]  Karen Birmingham,et al.  the heart , 2002, Nature.

[5]  A. Moss,et al.  Relation of the leukocyte count to recurrent cardiac events in stable patients after acute myocardial infarction. , 2001, The American journal of cardiology.

[6]  Michael C. Montalto,et al.  Inhibition of Mannose-Binding Lectin Reduces Postischemic Myocardial Reperfusion Injury , 2001, Circulation.

[7]  N. Brot,et al.  C-Reactive Protein Binds to Apoptotic Cells, Protects the Cells from Assembly of the Terminal Complement Components, and Sustains an Antiinflammatory Innate Immune Response , 2000, The Journal of experimental medicine.

[8]  C. Visser,et al.  Upregulation of ICAM-1 on cardiomyocytes in jeopardized human myocardium during infarction. , 1999, Cardiovascular research.

[9]  M. Weiser,et al.  Intestinal reperfusion injury is mediated by IgM and complement. , 1999, Journal of applied physiology.

[10]  P. Mcgeer,et al.  Human heart generates complement proteins that are upregulated and activated after myocardial infarction. , 1998, Circulation research.

[11]  C. Hack,et al.  Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. , 1997, Circulation.

[12]  S. Ogawa,et al.  C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. , 1997, Circulation.

[13]  G. Horstick,et al.  Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion. , 1997, Circulation.

[14]  C. Visser,et al.  C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. , 1997, Circulation.

[15]  A. Pasternack,et al.  Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. , 1996, European heart journal.

[16]  J. Schofer,et al.  Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrhythmias: a comparison between C6-competent and C6-deficient rabbits. , 1996, Cardiovascular research.

[17]  I. T. Ten Berge,et al.  CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes. , 1996, Journal of immunology.

[18]  M. Weiser,et al.  Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement , 1996, The Journal of experimental medicine.

[19]  A. M. Lefer,et al.  Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. , 1995, Circulation.

[20]  S. Rendig,et al.  Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs. , 1995, The American journal of physiology.

[21]  M. Cicardi,et al.  Activation of Complement and Kinin Systems After Thrombolytic Therapy in Patients With Acute Myocardial Infarction: A Comparison Between Streptokinase and Recombinant Tissue‐Type Plasminogen Activator , 1994, Circulation.

[22]  M. Entman,et al.  Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. , 1994, Cardiovascular research.

[23]  J. Schofer,et al.  Early accumulation of the terminal complement-complex in the ischaemic myocardium after reperfusion. , 1994, European heart journal.

[24]  M. Weisfeldt,et al.  Soluble Complement Receptor Type 1 Inhibits the Complement Pathway and Prevents Contractile Failure in the Postischemic Heart Evidence That Complement Activation Is Required for Neutrophil‐Mediated Reperfusion Injury , 1993, Circulation.

[25]  E. F. Smith,et al.  Reduction of myocardial reperfusion injury with human soluble complement receptor type 1 (BRL 55730). , 1993, European journal of pharmacology.

[26]  W. Dreyer,et al.  Kinetics of C5a release in cardiac lymph of dogs experiencing coronary artery ischemia-reperfusion injury. , 1992, Circulation research.

[27]  A. A. Taylor,et al.  Inflammation in the course of early myocardial ischemia , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  D. Mathey,et al.  Quantitative measurement of SC5b‐9 and C5b‐9(m) in infarcted areas of human myocardium , 1990, Clinical and experimental immunology.

[29]  M. Entman,et al.  Molecular Basis of Complement Activation in Ischemic Myocardium: Identification of Specific Molecules of Mitochondrial Origin That Bind Human Clq and Fix Complement , 1989, Circulation research.

[30]  R. Bolli,et al.  Activation of the complement system by recombinant tissue plasminogen activator. , 1987, Journal of the American College of Cardiology.

[31]  D. Mathey,et al.  Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. , 1986, Journal of immunology.

[32]  M. Entman,et al.  Selective Accumulation of the First Component of Complement and Leukocytes in Ischemic Canine Heart Muscle: A Possible Initiator of an Extra Myocardial Mechanism of Ischemic Injury , 1985, Circulation research.

[33]  L. McManus,et al.  Complement localization in ischemic baboon myocardium. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[34]  J. Volanakis.  COMPLEMENT ACTIVATION BY C‐REACTIVE PROTEIN COMPLEXES * , 1982, Annals of the New York Academy of Sciences.

[35]  P. Ward,et al.  THE PHLOGISTIC ROLE OF C3 LEUKOTACTIC FRAGMENTS IN MYOCARDIAL INFARCTS OF RATS , 1971, The Journal of experimental medicine.

[36]  O. Ratnoff,et al.  THE CONVERSION OF C'1S TO C'1 ESTERASE BY PLASMIN AND TRYPSIN , 1967, The Journal of experimental medicine.

[37]  P. White,et al.  The Speed of Healing of Myocardial Infarcts. , 1939, Transactions of the American Clinical and Climatological Association.